America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t ...

Biotechnology is a rapidly growing sector of the United States and global economies. Its products are increasingly important in diagnosis, prevention and treatment of disease. The Master of Science ...

China has pulled ahead of the United States in key areas of the life sciences, and the U.S. may only have a handful of years ...

CellCentric, a Cambridge-centric clinical stage biotechnology company, has opened a new office in Boston, marking a significant step in expanding its presence in the United States. The move will ...